International review of blood donation nucleic acid amplification testing
- Autores
- Faddy, Helen M.; Osiowy, Carla; Custer, Brian; Busch, Michael; Stramer, Susan L.; Adesina, Opeyemi; van de Laar, Thijs; Tsoi, Wai-Chiu; Styles, Claire; Kiely, Phil; Margaritis, Angelo; Kwon, So-Yong; Qiu, Yan; Deng, Xuelian; Lewin, Antoine; Jørgensen, Signe Winther; Erikstrup, Christian; Juhl, David; Sauleda, Silvia; Camacho Rodriguez, Bernardo Armando; Soto Coral, Lisbeth Jennifer Catherine; Gaviria García, Paula Andrea; Oota, Sineenart; O'Brien, Sheila F.; Wendel, Silvano; Castro, Emma; Navarro Pérez, Laura; Harvala, Heli; Davison, Katy; Reynolds, Claire; Jarvis, Lisa; Grabarczyk, Piotr; Kopacz, Aneta; Łętowska, Magdalena; O'Flaherty, Niamh; Young, Fiona; Williams, Padraig; Burke, Lisa; Chua, Sze Sze; Muylaert, An; Page, Isabel; Jones, Ann; Niederhauser, Christoph; Vermeulen, Marion; Laperche, Syria; Gallian, Pierre; Sawadogo, Salam; Satake, Masahiro; Gharehbaghian, Ahmad; Addas-Carvalho, Marcelo; Blanco, Sebastian; Gallego, Sandra Veronica; Seltsam, Axel; Weber Schehl, Marijke; Al-Riyami, Arwa Z.; Al Maamari, Khuloud; Alawi, Fatma Ba; Pandey, Hem Chandra; Mbanya, Dora; Azevedo França, Rochele; Charlewood, Richard
- Año de publicación
- 2024
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background and Objectives Nucleic acid amplification testing (NAT), in blood services context, is used for the detection of viral and parasite nucleic acids to reduce transfusion-transmitted infections. This project reviewed NAT for screening blood donations globally. Materials and Methods A survey on NAT usage, developed by the International Society of Blood Transfusion Working Party on Transfusion-transmitted Infectious Diseases (ISBT WP-TTID), was distributed through ISBT WP-TTID members. Data were analysed using descriptive statistics. Results Forty-three responses were received from 32 countries. Increased adoption of blood donation viral screening by NAT was observed over the past decade. NAT-positive donations were detected for all viruses tested in 2019 (proportion of donations positive by NAT were 0.0099% for human immunodeficiency virus [HIV], 0.0063% for hepatitis C virus [HCV], 0.0247% for hepatitis B virus [HBV], 0.0323% for hepatitis E virus [HEV], 0.0014% for West Nile virus [WNV] and 0.00005% for Zika virus [ZIKV]). Globally, over 3100 NAT-positive donations were identified as NAT yield or solely by NAT in 2019 and over 22,000 since the introduction of NAT, with HBV accounting for over half. NAT-positivity rate was higher in first-time donors for all viruses tested except WNV. During 2019, a small number of participants performed NAT for parasites (Trypanosoma cruzi, Babesia spp., Plasmodium spp.). Conclusion This survey captures current use of blood donation NAT globally. There has been increased NAT usage over the last decade. It is clear that NAT contributes to improving blood transfusion safety globally; however, there is a need to overcome economic barriers for regions/countries not performing NAT.
Fil: Faddy, Helen M.. School Of Health, University Of The Sunshine Coast,; Australia
Fil: Osiowy, Carla. Public Health Agency of Canada; Canadá
Fil: Custer, Brian. University of California San Francisco; Estados Unidos. Vitalant Research Institute; Estados Unidos
Fil: Busch, Michael. Vitalant Research Institute; Estados Unidos
Fil: Stramer, Susan L.. American Red Cross; Estados Unidos
Fil: Adesina, Opeyemi. Babcock University; Nigeria
Fil: van de Laar, Thijs. Sanquin Research; Países Bajos
Fil: Tsoi, Wai-Chiu. Hong Kong Red Cross Blood Transfusion Service; Hong Kong
Fil: Styles, Claire. Australian Red Cross Lifeblood; Australia
Fil: Kiely, Phil. Australian Red Cross Lifeblood; Australia
Fil: Margaritis, Angelo. Australian Red Cross Lifeblood; Australia
Fil: Kwon, So-Yong. Korean Red Cross Blood Services; Corea del Sur
Fil: Qiu, Yan. Beijing Red Cross Blood Centre; China
Fil: Deng, Xuelian. Dalian Blood Centre; China
Fil: Lewin, Antoine. Medical Affairs and Innovation, Héma-Québec; Canadá
Fil: Jørgensen, Signe Winther. University Aarhus; Dinamarca
Fil: Erikstrup, Christian. University Aarhus; Dinamarca
Fil: Juhl, David. University Hospital of Schleswig-Holstein. Institute of Transfusion Medicine; Alemania
Fil: Sauleda, Silvia. Banc de Sang i Teixits de Catalunya; España
Fil: Camacho Rodriguez, Bernardo Armando. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; Colombia
Fil: Soto Coral, Lisbeth Jennifer Catherine. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; Colombia
Fil: Gaviria García, Paula Andrea. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; Colombia
Fil: Oota, Sineenart. Thai Red Cross Society; Tailandia
Fil: O'Brien, Sheila F.. Canadian Blood Services; Canadá
Fil: Wendel, Silvano. Hospital Sírio-Libanês Blood Bank; Brasil
Fil: Castro, Emma. Centro de Transfusión de la Comunidad Valenciana; España
Fil: Navarro Pérez, Laura. Centro de Transfusión de la Comunidad Valenciana; España
Fil: Harvala, Heli. NHS Blood and Transplant; Reino Unido
Fil: Davison, Katy. NHSBT/UKHSA Epidemiology Unit; Reino Unido
Fil: Reynolds, Claire. NHSBT/UKHSA Epidemiology Unit; Reino Unido
Fil: Jarvis, Lisa. Scottish National Blood Transfusion Service; Reino Unido
Fil: Grabarczyk, Piotr. Institute of Hematology and Transfusion Medicine; Polonia
Fil: Kopacz, Aneta. Institute of Hematology and Transfusion Medicine; Polonia
Fil: Łętowska, Magdalena. Institute of Hematology and Transfusion Medicine; Polonia
Fil: O'Flaherty, Niamh. Irish Blood Transfusion Service; Reino Unido
Fil: Young, Fiona. Irish Blood Transfusion Service; Reino Unido
Fil: Williams, Padraig. Irish Blood Transfusion Service; Reino Unido
Fil: Burke, Lisa. Irish Blood Transfusion Service; Reino Unido
Fil: Chua, Sze Sze. Health Sciences Authority; Singapur
Fil: Muylaert, An. Red Cross Flanders; Bélgica
Fil: Page, Isabel. Centro de Hemoterapia y Hemodonacion de Castilla y Leon; España
Fil: Jones, Ann. Welsh Blood Service; Reino Unido
Fil: Niederhauser, Christoph. Interregional Blood Transfusion SRC; Suiza
Fil: Vermeulen, Marion. The South African National Blood Service; Sudáfrica
Fil: Laperche, Syria. Etablissement Français du Sang; Francia
Fil: Gallian, Pierre. Etablissement Français du Sang; Francia
Fil: Sawadogo, Salam. National Blood Transfusion Center of Burkina Faso; Burkina Faso
Fil: Satake, Masahiro. Japanese Red Cross Blood Service; Japón
Fil: Gharehbaghian, Ahmad. Shahid Beheshti University of Medical Sciences; Irán
Fil: Addas-Carvalho, Marcelo. Universidade Estadual de Campinas; Brasil
Fil: Blanco, Sebastian. Fundación Banco Central de Sangre; Argentina
Fil: Gallego, Sandra Veronica. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: Seltsam, Axel. Bavarian Red Cross Blood Donation Service; Alemania
Fil: Weber Schehl, Marijke. Bavarian Red Cross Blood Donation Service; Alemania
Fil: Al-Riyami, Arwa Z.. Sultan Qaboos University Hospital; Omán
Fil: Al Maamari, Khuloud. Sultan Qaboos University Hospital; Omán
Fil: Alawi, Fatma Ba. Sultan Qaboos University Hospital; Omán
Fil: Pandey, Hem Chandra. All India Institute of Medical Sciences; India
Fil: Mbanya, Dora. National Blood Transfusion Service; Camerún
Fil: Azevedo França, Rochele. Regional Blood Center of Ribeirão Preto; Brasil
Fil: Charlewood, Richard. New Zealand Blood Service; Nueva Zelanda - Materia
-
NAT
Blood
Virus
ITT - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/234532
Ver los metadatos del registro completo
id |
CONICETDig_8681ff4924de8ab02eb705064f1b737e |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/234532 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
International review of blood donation nucleic acid amplification testingFaddy, Helen M.Osiowy, CarlaCuster, BrianBusch, MichaelStramer, Susan L.Adesina, Opeyemivan de Laar, ThijsTsoi, Wai-ChiuStyles, ClaireKiely, PhilMargaritis, AngeloKwon, So-YongQiu, YanDeng, XuelianLewin, AntoineJørgensen, Signe WintherErikstrup, ChristianJuhl, DavidSauleda, SilviaCamacho Rodriguez, Bernardo ArmandoSoto Coral, Lisbeth Jennifer CatherineGaviria García, Paula AndreaOota, SineenartO'Brien, Sheila F.Wendel, SilvanoCastro, EmmaNavarro Pérez, LauraHarvala, HeliDavison, KatyReynolds, ClaireJarvis, LisaGrabarczyk, PiotrKopacz, AnetaŁętowska, MagdalenaO'Flaherty, NiamhYoung, FionaWilliams, PadraigBurke, LisaChua, Sze SzeMuylaert, AnPage, IsabelJones, AnnNiederhauser, ChristophVermeulen, MarionLaperche, SyriaGallian, PierreSawadogo, SalamSatake, MasahiroGharehbaghian, AhmadAddas-Carvalho, MarceloBlanco, SebastianGallego, Sandra VeronicaSeltsam, AxelWeber Schehl, MarijkeAl-Riyami, Arwa Z.Al Maamari, KhuloudAlawi, Fatma BaPandey, Hem ChandraMbanya, DoraAzevedo França, RocheleCharlewood, RichardNATBloodVirusITThttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Background and Objectives Nucleic acid amplification testing (NAT), in blood services context, is used for the detection of viral and parasite nucleic acids to reduce transfusion-transmitted infections. This project reviewed NAT for screening blood donations globally. Materials and Methods A survey on NAT usage, developed by the International Society of Blood Transfusion Working Party on Transfusion-transmitted Infectious Diseases (ISBT WP-TTID), was distributed through ISBT WP-TTID members. Data were analysed using descriptive statistics. Results Forty-three responses were received from 32 countries. Increased adoption of blood donation viral screening by NAT was observed over the past decade. NAT-positive donations were detected for all viruses tested in 2019 (proportion of donations positive by NAT were 0.0099% for human immunodeficiency virus [HIV], 0.0063% for hepatitis C virus [HCV], 0.0247% for hepatitis B virus [HBV], 0.0323% for hepatitis E virus [HEV], 0.0014% for West Nile virus [WNV] and 0.00005% for Zika virus [ZIKV]). Globally, over 3100 NAT-positive donations were identified as NAT yield or solely by NAT in 2019 and over 22,000 since the introduction of NAT, with HBV accounting for over half. NAT-positivity rate was higher in first-time donors for all viruses tested except WNV. During 2019, a small number of participants performed NAT for parasites (Trypanosoma cruzi, Babesia spp., Plasmodium spp.). Conclusion This survey captures current use of blood donation NAT globally. There has been increased NAT usage over the last decade. It is clear that NAT contributes to improving blood transfusion safety globally; however, there is a need to overcome economic barriers for regions/countries not performing NAT.Fil: Faddy, Helen M.. School Of Health, University Of The Sunshine Coast,; AustraliaFil: Osiowy, Carla. Public Health Agency of Canada; CanadáFil: Custer, Brian. University of California San Francisco; Estados Unidos. Vitalant Research Institute; Estados UnidosFil: Busch, Michael. Vitalant Research Institute; Estados UnidosFil: Stramer, Susan L.. American Red Cross; Estados UnidosFil: Adesina, Opeyemi. Babcock University; NigeriaFil: van de Laar, Thijs. Sanquin Research; Países BajosFil: Tsoi, Wai-Chiu. Hong Kong Red Cross Blood Transfusion Service; Hong KongFil: Styles, Claire. Australian Red Cross Lifeblood; AustraliaFil: Kiely, Phil. Australian Red Cross Lifeblood; AustraliaFil: Margaritis, Angelo. Australian Red Cross Lifeblood; AustraliaFil: Kwon, So-Yong. Korean Red Cross Blood Services; Corea del SurFil: Qiu, Yan. Beijing Red Cross Blood Centre; ChinaFil: Deng, Xuelian. Dalian Blood Centre; ChinaFil: Lewin, Antoine. Medical Affairs and Innovation, Héma-Québec; CanadáFil: Jørgensen, Signe Winther. University Aarhus; DinamarcaFil: Erikstrup, Christian. University Aarhus; DinamarcaFil: Juhl, David. University Hospital of Schleswig-Holstein. Institute of Transfusion Medicine; AlemaniaFil: Sauleda, Silvia. Banc de Sang i Teixits de Catalunya; EspañaFil: Camacho Rodriguez, Bernardo Armando. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; ColombiaFil: Soto Coral, Lisbeth Jennifer Catherine. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; ColombiaFil: Gaviria García, Paula Andrea. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; ColombiaFil: Oota, Sineenart. Thai Red Cross Society; TailandiaFil: O'Brien, Sheila F.. Canadian Blood Services; CanadáFil: Wendel, Silvano. Hospital Sírio-Libanês Blood Bank; BrasilFil: Castro, Emma. Centro de Transfusión de la Comunidad Valenciana; EspañaFil: Navarro Pérez, Laura. Centro de Transfusión de la Comunidad Valenciana; EspañaFil: Harvala, Heli. NHS Blood and Transplant; Reino UnidoFil: Davison, Katy. NHSBT/UKHSA Epidemiology Unit; Reino UnidoFil: Reynolds, Claire. NHSBT/UKHSA Epidemiology Unit; Reino UnidoFil: Jarvis, Lisa. Scottish National Blood Transfusion Service; Reino UnidoFil: Grabarczyk, Piotr. Institute of Hematology and Transfusion Medicine; PoloniaFil: Kopacz, Aneta. Institute of Hematology and Transfusion Medicine; PoloniaFil: Łętowska, Magdalena. Institute of Hematology and Transfusion Medicine; PoloniaFil: O'Flaherty, Niamh. Irish Blood Transfusion Service; Reino UnidoFil: Young, Fiona. Irish Blood Transfusion Service; Reino UnidoFil: Williams, Padraig. Irish Blood Transfusion Service; Reino UnidoFil: Burke, Lisa. Irish Blood Transfusion Service; Reino UnidoFil: Chua, Sze Sze. Health Sciences Authority; SingapurFil: Muylaert, An. Red Cross Flanders; BélgicaFil: Page, Isabel. Centro de Hemoterapia y Hemodonacion de Castilla y Leon; EspañaFil: Jones, Ann. Welsh Blood Service; Reino UnidoFil: Niederhauser, Christoph. Interregional Blood Transfusion SRC; SuizaFil: Vermeulen, Marion. The South African National Blood Service; SudáfricaFil: Laperche, Syria. Etablissement Français du Sang; FranciaFil: Gallian, Pierre. Etablissement Français du Sang; FranciaFil: Sawadogo, Salam. National Blood Transfusion Center of Burkina Faso; Burkina FasoFil: Satake, Masahiro. Japanese Red Cross Blood Service; JapónFil: Gharehbaghian, Ahmad. Shahid Beheshti University of Medical Sciences; IránFil: Addas-Carvalho, Marcelo. Universidade Estadual de Campinas; BrasilFil: Blanco, Sebastian. Fundación Banco Central de Sangre; ArgentinaFil: Gallego, Sandra Veronica. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; ArgentinaFil: Seltsam, Axel. Bavarian Red Cross Blood Donation Service; AlemaniaFil: Weber Schehl, Marijke. Bavarian Red Cross Blood Donation Service; AlemaniaFil: Al-Riyami, Arwa Z.. Sultan Qaboos University Hospital; OmánFil: Al Maamari, Khuloud. Sultan Qaboos University Hospital; OmánFil: Alawi, Fatma Ba. Sultan Qaboos University Hospital; OmánFil: Pandey, Hem Chandra. All India Institute of Medical Sciences; IndiaFil: Mbanya, Dora. National Blood Transfusion Service; CamerúnFil: Azevedo França, Rochele. Regional Blood Center of Ribeirão Preto; BrasilFil: Charlewood, Richard. New Zealand Blood Service; Nueva ZelandaJohn Wiley and Sons Inc2024-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/234532Faddy, Helen M.; Osiowy, Carla; Custer, Brian; Busch, Michael; Stramer, Susan L.; et al.; International review of blood donation nucleic acid amplification testing; John Wiley and Sons Inc; Vox Sanguinis; 119; 4; 2-2024; 315-3251423-0410CONICET DigitalCONICETenghttps://ri.conicet.gov.ar/handle/11336/234526info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1111/vox.13592info:eu-repo/semantics/altIdentifier/doi/10.1111/vox.13592info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:49:35Zoai:ri.conicet.gov.ar:11336/234532instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:49:36.1CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
International review of blood donation nucleic acid amplification testing |
title |
International review of blood donation nucleic acid amplification testing |
spellingShingle |
International review of blood donation nucleic acid amplification testing Faddy, Helen M. NAT Blood Virus ITT |
title_short |
International review of blood donation nucleic acid amplification testing |
title_full |
International review of blood donation nucleic acid amplification testing |
title_fullStr |
International review of blood donation nucleic acid amplification testing |
title_full_unstemmed |
International review of blood donation nucleic acid amplification testing |
title_sort |
International review of blood donation nucleic acid amplification testing |
dc.creator.none.fl_str_mv |
Faddy, Helen M. Osiowy, Carla Custer, Brian Busch, Michael Stramer, Susan L. Adesina, Opeyemi van de Laar, Thijs Tsoi, Wai-Chiu Styles, Claire Kiely, Phil Margaritis, Angelo Kwon, So-Yong Qiu, Yan Deng, Xuelian Lewin, Antoine Jørgensen, Signe Winther Erikstrup, Christian Juhl, David Sauleda, Silvia Camacho Rodriguez, Bernardo Armando Soto Coral, Lisbeth Jennifer Catherine Gaviria García, Paula Andrea Oota, Sineenart O'Brien, Sheila F. Wendel, Silvano Castro, Emma Navarro Pérez, Laura Harvala, Heli Davison, Katy Reynolds, Claire Jarvis, Lisa Grabarczyk, Piotr Kopacz, Aneta Łętowska, Magdalena O'Flaherty, Niamh Young, Fiona Williams, Padraig Burke, Lisa Chua, Sze Sze Muylaert, An Page, Isabel Jones, Ann Niederhauser, Christoph Vermeulen, Marion Laperche, Syria Gallian, Pierre Sawadogo, Salam Satake, Masahiro Gharehbaghian, Ahmad Addas-Carvalho, Marcelo Blanco, Sebastian Gallego, Sandra Veronica Seltsam, Axel Weber Schehl, Marijke Al-Riyami, Arwa Z. Al Maamari, Khuloud Alawi, Fatma Ba Pandey, Hem Chandra Mbanya, Dora Azevedo França, Rochele Charlewood, Richard |
author |
Faddy, Helen M. |
author_facet |
Faddy, Helen M. Osiowy, Carla Custer, Brian Busch, Michael Stramer, Susan L. Adesina, Opeyemi van de Laar, Thijs Tsoi, Wai-Chiu Styles, Claire Kiely, Phil Margaritis, Angelo Kwon, So-Yong Qiu, Yan Deng, Xuelian Lewin, Antoine Jørgensen, Signe Winther Erikstrup, Christian Juhl, David Sauleda, Silvia Camacho Rodriguez, Bernardo Armando Soto Coral, Lisbeth Jennifer Catherine Gaviria García, Paula Andrea Oota, Sineenart O'Brien, Sheila F. Wendel, Silvano Castro, Emma Navarro Pérez, Laura Harvala, Heli Davison, Katy Reynolds, Claire Jarvis, Lisa Grabarczyk, Piotr Kopacz, Aneta Łętowska, Magdalena O'Flaherty, Niamh Young, Fiona Williams, Padraig Burke, Lisa Chua, Sze Sze Muylaert, An Page, Isabel Jones, Ann Niederhauser, Christoph Vermeulen, Marion Laperche, Syria Gallian, Pierre Sawadogo, Salam Satake, Masahiro Gharehbaghian, Ahmad Addas-Carvalho, Marcelo Blanco, Sebastian Gallego, Sandra Veronica Seltsam, Axel Weber Schehl, Marijke Al-Riyami, Arwa Z. Al Maamari, Khuloud Alawi, Fatma Ba Pandey, Hem Chandra Mbanya, Dora Azevedo França, Rochele Charlewood, Richard |
author_role |
author |
author2 |
Osiowy, Carla Custer, Brian Busch, Michael Stramer, Susan L. Adesina, Opeyemi van de Laar, Thijs Tsoi, Wai-Chiu Styles, Claire Kiely, Phil Margaritis, Angelo Kwon, So-Yong Qiu, Yan Deng, Xuelian Lewin, Antoine Jørgensen, Signe Winther Erikstrup, Christian Juhl, David Sauleda, Silvia Camacho Rodriguez, Bernardo Armando Soto Coral, Lisbeth Jennifer Catherine Gaviria García, Paula Andrea Oota, Sineenart O'Brien, Sheila F. Wendel, Silvano Castro, Emma Navarro Pérez, Laura Harvala, Heli Davison, Katy Reynolds, Claire Jarvis, Lisa Grabarczyk, Piotr Kopacz, Aneta Łętowska, Magdalena O'Flaherty, Niamh Young, Fiona Williams, Padraig Burke, Lisa Chua, Sze Sze Muylaert, An Page, Isabel Jones, Ann Niederhauser, Christoph Vermeulen, Marion Laperche, Syria Gallian, Pierre Sawadogo, Salam Satake, Masahiro Gharehbaghian, Ahmad Addas-Carvalho, Marcelo Blanco, Sebastian Gallego, Sandra Veronica Seltsam, Axel Weber Schehl, Marijke Al-Riyami, Arwa Z. Al Maamari, Khuloud Alawi, Fatma Ba Pandey, Hem Chandra Mbanya, Dora Azevedo França, Rochele Charlewood, Richard |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
NAT Blood Virus ITT |
topic |
NAT Blood Virus ITT |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Background and Objectives Nucleic acid amplification testing (NAT), in blood services context, is used for the detection of viral and parasite nucleic acids to reduce transfusion-transmitted infections. This project reviewed NAT for screening blood donations globally. Materials and Methods A survey on NAT usage, developed by the International Society of Blood Transfusion Working Party on Transfusion-transmitted Infectious Diseases (ISBT WP-TTID), was distributed through ISBT WP-TTID members. Data were analysed using descriptive statistics. Results Forty-three responses were received from 32 countries. Increased adoption of blood donation viral screening by NAT was observed over the past decade. NAT-positive donations were detected for all viruses tested in 2019 (proportion of donations positive by NAT were 0.0099% for human immunodeficiency virus [HIV], 0.0063% for hepatitis C virus [HCV], 0.0247% for hepatitis B virus [HBV], 0.0323% for hepatitis E virus [HEV], 0.0014% for West Nile virus [WNV] and 0.00005% for Zika virus [ZIKV]). Globally, over 3100 NAT-positive donations were identified as NAT yield or solely by NAT in 2019 and over 22,000 since the introduction of NAT, with HBV accounting for over half. NAT-positivity rate was higher in first-time donors for all viruses tested except WNV. During 2019, a small number of participants performed NAT for parasites (Trypanosoma cruzi, Babesia spp., Plasmodium spp.). Conclusion This survey captures current use of blood donation NAT globally. There has been increased NAT usage over the last decade. It is clear that NAT contributes to improving blood transfusion safety globally; however, there is a need to overcome economic barriers for regions/countries not performing NAT. Fil: Faddy, Helen M.. School Of Health, University Of The Sunshine Coast,; Australia Fil: Osiowy, Carla. Public Health Agency of Canada; Canadá Fil: Custer, Brian. University of California San Francisco; Estados Unidos. Vitalant Research Institute; Estados Unidos Fil: Busch, Michael. Vitalant Research Institute; Estados Unidos Fil: Stramer, Susan L.. American Red Cross; Estados Unidos Fil: Adesina, Opeyemi. Babcock University; Nigeria Fil: van de Laar, Thijs. Sanquin Research; Países Bajos Fil: Tsoi, Wai-Chiu. Hong Kong Red Cross Blood Transfusion Service; Hong Kong Fil: Styles, Claire. Australian Red Cross Lifeblood; Australia Fil: Kiely, Phil. Australian Red Cross Lifeblood; Australia Fil: Margaritis, Angelo. Australian Red Cross Lifeblood; Australia Fil: Kwon, So-Yong. Korean Red Cross Blood Services; Corea del Sur Fil: Qiu, Yan. Beijing Red Cross Blood Centre; China Fil: Deng, Xuelian. Dalian Blood Centre; China Fil: Lewin, Antoine. Medical Affairs and Innovation, Héma-Québec; Canadá Fil: Jørgensen, Signe Winther. University Aarhus; Dinamarca Fil: Erikstrup, Christian. University Aarhus; Dinamarca Fil: Juhl, David. University Hospital of Schleswig-Holstein. Institute of Transfusion Medicine; Alemania Fil: Sauleda, Silvia. Banc de Sang i Teixits de Catalunya; España Fil: Camacho Rodriguez, Bernardo Armando. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; Colombia Fil: Soto Coral, Lisbeth Jennifer Catherine. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; Colombia Fil: Gaviria García, Paula Andrea. Instituto Distrital de Ciencia Biotecnología e Innovación en Salud; Colombia Fil: Oota, Sineenart. Thai Red Cross Society; Tailandia Fil: O'Brien, Sheila F.. Canadian Blood Services; Canadá Fil: Wendel, Silvano. Hospital Sírio-Libanês Blood Bank; Brasil Fil: Castro, Emma. Centro de Transfusión de la Comunidad Valenciana; España Fil: Navarro Pérez, Laura. Centro de Transfusión de la Comunidad Valenciana; España Fil: Harvala, Heli. NHS Blood and Transplant; Reino Unido Fil: Davison, Katy. NHSBT/UKHSA Epidemiology Unit; Reino Unido Fil: Reynolds, Claire. NHSBT/UKHSA Epidemiology Unit; Reino Unido Fil: Jarvis, Lisa. Scottish National Blood Transfusion Service; Reino Unido Fil: Grabarczyk, Piotr. Institute of Hematology and Transfusion Medicine; Polonia Fil: Kopacz, Aneta. Institute of Hematology and Transfusion Medicine; Polonia Fil: Łętowska, Magdalena. Institute of Hematology and Transfusion Medicine; Polonia Fil: O'Flaherty, Niamh. Irish Blood Transfusion Service; Reino Unido Fil: Young, Fiona. Irish Blood Transfusion Service; Reino Unido Fil: Williams, Padraig. Irish Blood Transfusion Service; Reino Unido Fil: Burke, Lisa. Irish Blood Transfusion Service; Reino Unido Fil: Chua, Sze Sze. Health Sciences Authority; Singapur Fil: Muylaert, An. Red Cross Flanders; Bélgica Fil: Page, Isabel. Centro de Hemoterapia y Hemodonacion de Castilla y Leon; España Fil: Jones, Ann. Welsh Blood Service; Reino Unido Fil: Niederhauser, Christoph. Interregional Blood Transfusion SRC; Suiza Fil: Vermeulen, Marion. The South African National Blood Service; Sudáfrica Fil: Laperche, Syria. Etablissement Français du Sang; Francia Fil: Gallian, Pierre. Etablissement Français du Sang; Francia Fil: Sawadogo, Salam. National Blood Transfusion Center of Burkina Faso; Burkina Faso Fil: Satake, Masahiro. Japanese Red Cross Blood Service; Japón Fil: Gharehbaghian, Ahmad. Shahid Beheshti University of Medical Sciences; Irán Fil: Addas-Carvalho, Marcelo. Universidade Estadual de Campinas; Brasil Fil: Blanco, Sebastian. Fundación Banco Central de Sangre; Argentina Fil: Gallego, Sandra Veronica. Universidad Nacional de Córdoba. Facultad de Medicina. Instituto de Virología Dr. J. M. Vanella; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina Fil: Seltsam, Axel. Bavarian Red Cross Blood Donation Service; Alemania Fil: Weber Schehl, Marijke. Bavarian Red Cross Blood Donation Service; Alemania Fil: Al-Riyami, Arwa Z.. Sultan Qaboos University Hospital; Omán Fil: Al Maamari, Khuloud. Sultan Qaboos University Hospital; Omán Fil: Alawi, Fatma Ba. Sultan Qaboos University Hospital; Omán Fil: Pandey, Hem Chandra. All India Institute of Medical Sciences; India Fil: Mbanya, Dora. National Blood Transfusion Service; Camerún Fil: Azevedo França, Rochele. Regional Blood Center of Ribeirão Preto; Brasil Fil: Charlewood, Richard. New Zealand Blood Service; Nueva Zelanda |
description |
Background and Objectives Nucleic acid amplification testing (NAT), in blood services context, is used for the detection of viral and parasite nucleic acids to reduce transfusion-transmitted infections. This project reviewed NAT for screening blood donations globally. Materials and Methods A survey on NAT usage, developed by the International Society of Blood Transfusion Working Party on Transfusion-transmitted Infectious Diseases (ISBT WP-TTID), was distributed through ISBT WP-TTID members. Data were analysed using descriptive statistics. Results Forty-three responses were received from 32 countries. Increased adoption of blood donation viral screening by NAT was observed over the past decade. NAT-positive donations were detected for all viruses tested in 2019 (proportion of donations positive by NAT were 0.0099% for human immunodeficiency virus [HIV], 0.0063% for hepatitis C virus [HCV], 0.0247% for hepatitis B virus [HBV], 0.0323% for hepatitis E virus [HEV], 0.0014% for West Nile virus [WNV] and 0.00005% for Zika virus [ZIKV]). Globally, over 3100 NAT-positive donations were identified as NAT yield or solely by NAT in 2019 and over 22,000 since the introduction of NAT, with HBV accounting for over half. NAT-positivity rate was higher in first-time donors for all viruses tested except WNV. During 2019, a small number of participants performed NAT for parasites (Trypanosoma cruzi, Babesia spp., Plasmodium spp.). Conclusion This survey captures current use of blood donation NAT globally. There has been increased NAT usage over the last decade. It is clear that NAT contributes to improving blood transfusion safety globally; however, there is a need to overcome economic barriers for regions/countries not performing NAT. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-02 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/234532 Faddy, Helen M.; Osiowy, Carla; Custer, Brian; Busch, Michael; Stramer, Susan L.; et al.; International review of blood donation nucleic acid amplification testing; John Wiley and Sons Inc; Vox Sanguinis; 119; 4; 2-2024; 315-325 1423-0410 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/234532 |
identifier_str_mv |
Faddy, Helen M.; Osiowy, Carla; Custer, Brian; Busch, Michael; Stramer, Susan L.; et al.; International review of blood donation nucleic acid amplification testing; John Wiley and Sons Inc; Vox Sanguinis; 119; 4; 2-2024; 315-325 1423-0410 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://ri.conicet.gov.ar/handle/11336/234526 info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1111/vox.13592 info:eu-repo/semantics/altIdentifier/doi/10.1111/vox.13592 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
John Wiley and Sons Inc |
publisher.none.fl_str_mv |
John Wiley and Sons Inc |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268982094069760 |
score |
13.13397 |